May 16, 2025 - 14:04

STOCKHOLM, May 16, 2025—ROYC, a prominent provider of comprehensive operating systems for private markets, has announced its collaboration with The Riverside Company to structure a new access fund aimed at Private Wealth. This initiative marks a significant step forward in providing investors with enhanced opportunities in the European market.
The Riverside Company, a well-established global private equity firm, specializes in investing in promising businesses valued at up to $400 million. Since its inception in 1988, Riverside has successfully completed over 1,000 investments, accumulating more than $12 billion in assets under management. This partnership with ROYC is expected to leverage Riverside's extensive experience and robust investment strategy, offering investors a unique vehicle to access the private equity landscape.
As the demand for innovative investment solutions continues to grow, this new fund is poised to attract a wide range of investors seeking to diversify their portfolios and capitalize on emerging opportunities within the private markets. With ROYC's technological expertise and Riverside's investment acumen, the collaboration aims to redefine wealth access in Europe.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...